A screening test is available to identify individuals with a genetic mutation that puts them at greater risk for stroke. The test is extremely expensive and is not covered by most insurance plans, so those choosing to have the test usually have to pay for it out-of-pocket. However, it has been determined that the screening test is very valuable because the annual incidence of stroke among those who have been screened is nearly half that of the general population.